About: Nyrada Inc., a clinical-stage biotechnology company, focuses on the discovery and development of small-molecule therapies for neuroprotection and cardioprotection indications in Australasia. Its lead candidate is Xolatryp, a small-molecule inhibitor targeting the transient receptor potential canonical ion channel subtypes 3, 6, and 7, which is in a Phase IIa clinical trial to treat myocardial ischemia, arrhythmia, stroke, and traumatic brain injury, as well as in a preclinical research stage for oncology indications. Nyrada Inc. was incorporated in 2017 and is based in Sydney, Australia.
Sector: Healthcare
Industry: Biotechnology
Latest price: A$0.46 (-6.12%)
NYR ASX Nyrada Inc
Nyrada Inc share price
Atividade de preço de NYR
Último preço
$ 0,460
Variação (24h)
-0,03 AUD (6,12%)
Volume
117.44K
Volume (média 4 sem.)
-
Abertura
$ 0,49
Variação do dia
$ 0,46 - $ 0,49
Fechamento anterior
$ 0,49
Último negócio
30 Oct, 5:10 am GMT+0
Atrasado
30 Oct, 5:10 am GMT+0
NYR price performance
Atrasado
30 Oct, 5:10 am GMT+0
quote.marketSignals